SEC Company Response from STRATA Skin Sciences, Inc. (SSKN) (CIK 0001051514) (SSKN) — Oct 7, 2005
STRATA Skin Sciences, Inc. (SSKN) (CIK 0001051514)
Date: Oct. 7, 2005 · CIK: 0001051514 · Accession: 0000950123-05-011948
AI Filing Summary & Sentiment
File numbers found in text: 333-125517
Referenced dates: July 30, 1997
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
<PAGE>
DREIER LLP
Attorneys at Law
499 Park Avenue Valerie A. Price
New York, New York 10022 Direct Dial: (212) 328-6144
Tel: (212) 328-6100 Direct Fax: (212) 652-3789
Facsimile: (212) 328-6101 Partner
vprice@dreierllp.com
October 6, 2005
SENT VIA FAX AND FEDERAL EXPRESS
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Attention: Russell Mancuso, Branch Chief, Division of Corporation Finance
Re: Electro-Optical Sciences, Inc.
Registration Statement on Form S-1
Filed June 3, 2005
File No. 333-125517
Ladies and Gentlemen:
On behalf of Electro-Optical Sciences, Inc., a Delaware corporation
(the "Company"), and as authorized by the Company, we are responding to the
comment letter sent to Joseph V. Gulfo, M.D. of the Company, dated October 4,
2005, from the Staff of the Commission.
We have referenced the appropriate page numbers of the prospectus
contained in Amendment No. 4 to the above-captioned Registration Statement on
Form S-1 ("Amendment No. 4") in our responses contained herein. The numbered
paragraphs below set forth the Staff's comments together with our responses.
Unless otherwise indicated, capitalized terms used herein have the meanings
assigned to them in Amendment No. 4.
General
1. Tell us your plans to recirculate the prospectus so investors receive the
changes since Amendment 3 to your registration statement.
Response: The preliminary prospectus included in Amendment No. 4 was
reprinted and has been, or will be, delivered to all potential
investors.
Special Suitability for California Residents, page i
<PAGE>
Russell Mancuso, Branch Chief, Division of Corporation Finance
October 6, 2005
Page 2
2. Tell us the reason for this requirement. Also tell us why purchasers
would not have a resale exemption under Section 4(1) of the Securities
Act.
Response: The Company anticipates that its common stock may be purchased
by natural persons resident in California. Because the Company has applied
to have its common stock included for quotation on the NASDAQ SmallCap
Market, not the NASDAQ National Market, its common stock is not a "covered
security" under the National Securities Markets Improvement Act of 1996,
and thus the Company believes that the offer and sale of its common stock
to natural persons resident in California will be subject to merit review
by the Securities Regulation Division of the California Department of
Corporations. Applicable California securities law permits "limited
qualification" offerings of securities. The Company believes that a merit
review of a limited qualification offering is more likely to be completed
in the Company's anticipated timeframe for the offering than a merit
review that is part of an "open qualification" offering. A limited
qualification offering requires compliance with certain investor
suitability standards. Accordingly, the Company chose to impose such
standards on California residents in order to offer its common stock
pursuant to a limited qualification under applicable California securities
law.
The Company believes that purchasers of its common stock resident in
California would be able to resell their shares under Section 4(1) of the
Securities Act of 1933 and under Section 25101.1(a) of the California
Corporate Securities Law.
Summary, page 1
3. If financial results for the quarter ended September 30, 2005 are
available, please update your prospectus. If only partial results are
known, disclose any material recent developments and ensure that
corresponding updates are made throughout the prospectus. We note, for
example, that your accumulated deficit disclosure on page 10 is as of June
30, 2005.
Response: The Company anticipates that the offering will be consummated
before the financial results for the quarter ended September 30, 2005 are
available. Based on the partial results currently known, the Company
believes that there are no material developments which have not been
disclosed in the prospectus.
Management's discussion and analysis of financial condition and results of
operations, page 36
Liquidity and Capital Resources, page 41
4. We refer you to your disclosure in the last paragraph of this section.
Please clarify what you mean by the proceeds of this offering might not be
available in amounts or on terms acceptable to you.
<PAGE>
Russell Mancuso, Branch Chief, Division of Corporation Finance
October 6, 2005
Page 3
Response: In response to Comment 4, we will revise the referenced
disclosure on page 41 to read as follows:
"If this offering is not consummated, we would need to limit the level of
discretionary expenditures, and would need to pursue alternative sources
of funding to sustain the continued development of the Melafind(R) device
at the same level."
Business, page 44
Manufacturing, page 56
5. Please update us as to the status of your contract negotiation with Carl
Zeiss Jena. We refer you to your disclosure in the first full paragraph on
page 56.
Response: The Company remains in active negotiations with Carl Zeiss Jena
regarding a supply agreement for the lens to be used in the post-clinical
trial models of the hand-held clinical units. While the Company believes
that negotiations are proceeding in a positive direction, the Company does
not expect negotiations to be completed prior to consummation of the
offering. Accordingly, the Company believes that the referenced disclosure
remains appropriate.
Underwriting, page 87
6. Please identify any members of the underwriting syndicate that will engage
in any electronic offer, sale or distribution of the shares and describe
their procedures to us supplementally. If you become aware of any
additional members of the underwriting syndicate that may engage in
electronic offers, sales or distributions after you respond to this
comment, promptly supplement your response to identify those members and
provide us with a description of their procedures.
In your discussion of the procedures, tell us how your procedures ensure
that the distribution complies with Section 5 of the Securities Act. In
particular:
- The communications used;
- The availability of the preliminary prospectus;
- The manner of conducting the distribution and sale, like the use of
indications of interest or conditional offers; and
- The funding of an account and payment of the purchase price.
Finally, tell us whether you or the underwriters have any arrangements
with a third party to host or access your preliminary prospectus on the
Internet. If so, identify the party
<PAGE>
Russell Mancuso, Branch Chief, Division of Corporation Finance
October 6, 2005
Page 4
and the website, describe the material terms of your agreement and provide
us with a copy of any written agreement. Provide us also with copies of
all information concerning your company or prospectus that has appeared on
their website. Again, if you subsequently enter into any arrangements like
this, promptly supplement your response.
Response: The underwriters have informed the Company that, except for the
electronic delivery directly to offerees of prospectuses and an electronic
roadshow (each of which is discussed below), they do not intend to offer
and/or sell securities electronically. The underwriters have also advised
the Company that they have no arrangement with a third party to host or
access the preliminary prospectus on the Internet except for the delivery
directly to offerrees of prospectuses electronically in "pdf" format with
no alterations from the printed prospectus (all of such electronic
deliveries to be followed by delivery of a printed prospectus). While the
underwriters have contracted with NetRoadshow, Inc. (www.netroadshow.com)
to conduct an Internet roadshow, the purpose of this contract is not
specifically to host or access the preliminary prospectus. The primary
purpose of the Internet roadshow is to provide access to the roadshow to
institutional investors that cannot, or elect not to, attend roadshow
meetings in person. NetRoadshow, Inc. has informed the underwriters that
it conducts Internet roadshows in accordance with the NetRoadshow, Inc.
no-action letter dated July 30, 1997 received from the Commission in
connection with virtual roadshows. In accordance with such no-action
letter, an electronic version of the preliminary prospectus, identical to
the copy filed with the Commission and delivered to live attendees, is
required to, and will, be made available on the NetRoadshow, Inc. website.
Exhibit 5.1
7. Please ask your counsel to confirm to us in writing that it concurs with
our understanding that the reference and limitation to the Delaware
General Corporate Law includes the statutory provisions and also all
applicable provisions of the Delaware Constitution. Counsel should file
this written confirmation as correspondence on the EDGAR system.
Response: In response to Comment 7, we will revise Exhibit 5.1 to
include the following statement:
As used herein, the term "Delaware General Corporation Law, as amended"
includes the statutory provisions contained therein, all applicable
provisions of the Delaware Constitution and reported judicial decisions
interpreting these laws.
8. We note the fact that counsel will undertake no obligation to update the
opinion. Given the limitation, please file an opinion dates as of the
effective date of the registration statement as an exhibit to a final
pre-effective amendment to your registration statement.
<PAGE>
Russell Mancuso, Branch Chief, Division of Corporation Finance
October 6, 2005
Page 5
Response: An opinion dated the effective date of the registration
statement will be filed as an exhibit to the Registration Statement.
9. Given the assumption in the penultimate paragraph regarding the shares
being issued and sold as described in the registration statement, it is
unclear why the remaining assumptions in that paragraph are necessary and
appropriate. Please tell us what board resolutions are not and will not be
reflected in the registration statement.
Response: In response to Comment 9, we will revise Exhibit 5.1 to replace
the phrase "to be adopted by the Pricing Committee of the Board of
Directors of the Company" in the penultimate paragraph of the opinion with
the phrase "resolutions to be adopted by the Pricing Committee of the
Board of Directors of the Company establishing the public offering price
of the shares."
* * * *
We hope that the foregoing has been responsive to the Staff's comments.
Should you have any questions relating to any of the foregoing, please
feel free to contact the undersigned at (212) 328-6144. Thank you for your
cooperation and attention to this matter.
Very truly yours,
/s/ Valerie A. Price
Valerie A. Price, Esq.
VAP/ma
Enclosure
cc: Joseph V. Gulfo, M.D
Karen Krumeich
William Bronner
Lewis B. Leventhal, CPA
David C. Peck, Esq.
</TEXT>
</DOCUMENT>